(AD) Koninklijke Ahold Delhaize - Ratings and Ratios
Groceries, Pharmacy, Liquor, Gasoline, E-Commerce
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.52% |
| Yield on Cost 5y | 5.97% |
| Yield CAGR 5y | 9.19% |
| Payout Consistency | 79.3% |
| Payout Ratio | 44.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 16.7% |
| Value at Risk 5%th | 26.5% |
| Relative Tail Risk | -3.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.26 |
| Alpha | -5.74 |
| CAGR/Max DD | 0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.485 |
| Beta | -0.067 |
| Beta Downside | -0.169 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.67% |
| Mean DD | 5.92% |
| Median DD | 5.03% |
Description: AD Koninklijke Ahold Delhaize December 17, 2025
Koninklijke Ahold Delhaize N.V. (ticker AD) is a multinational food-retail operator headquartered in Zaandam, the Netherlands. It runs supermarkets, convenience stores and e-commerce sites across the Netherlands, the United States and several international markets under brands such as Albert, Delhaize, Food Lion, Giant, Stop & Shop, and Super Indo, offering a full assortment from fresh produce to pharmacy items and gasoline.
In FY 2023 the company reported a 4 % same-store sales increase in its U.S. segment and a 10 % year-over-year rise in online grocery revenue, reflecting the broader industry shift toward omnichannel shopping. Operating margins hovered around 4.5 %, while private-label sales now represent roughly 30 % of total revenue-a key lever for margin expansion. Core economic drivers include inflation-linked price sensitivity in discretionary categories (beer, wine, tobacco) and rising labor costs, which together constrain earnings growth unless offset by efficiency gains and price-elasticity management.
For a deeper dive into AD’s valuation nuances, the ValueRay platform offers a data-rich toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 2.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.85 > 1.0 |
| NWC/Revenue: -5.57% < 20% (prev -3.63%; Δ -1.94% < -1%) |
| CFO/TA 0.13 > 3% & CFO 6.60b > Net Income 2.07b |
| Net Debt (805.0m) to EBITDA (7.12b): 0.11 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (902.0m) vs 12m ago -2.09% < -2% |
| Gross Margin: 26.45% > 18% (prev 0.27%; Δ 2618 % > 0.5%) |
| Asset Turnover: 190.7% > 50% (prev 187.1%; Δ 3.54% > 0%) |
| Interest Coverage Ratio: 4.30 > 6 (EBITDA TTM 7.12b / Interest Expense TTM 799.0m) |
Altman Z'' 0.52
| A: -0.10 (Total Current Assets 12.14b - Total Current Liabilities 17.27b) / Total Assets 49.03b |
| B: 0.16 (Retained Earnings 7.70b / Total Assets 49.03b) |
| C: 0.07 (EBIT TTM 3.44b / Avg Total Assets 48.32b) |
| D: 0.20 (Book Value of Equity 7.14b / Total Liabilities 35.17b) |
| Altman-Z'' Score: 0.52 = B |
Beneish M -3.07
| DSRI: 0.99 (Receivables 2.51b/2.44b, Revenue 92.14b/89.10b) |
| GMI: 1.02 (GM 26.45% / 26.88%) |
| AQI: 1.03 (AQ_t 0.33 / AQ_t-1 0.32) |
| SGI: 1.03 (Revenue 92.14b / 89.10b) |
| TATA: -0.09 (NI 2.07b - CFO 6.60b) / TA 49.03b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
ValueRay F-Score (Strict, 0-100) 77.61
| 1. Piotroski: 7.0pt |
| 2. FCF Yield: 15.99% |
| 3. FCF Margin: 5.17% |
| 4. Debt/Equity: 0.33 |
| 5. Debt/Ebitda: 0.11 |
| 6. ROIC - WACC: 7.91% |
| 7. RoE: 14.04% |
| 8. Revenue Trend: 67.26% |
| 9. EPS Trend: -34.30% |
What is the price of AD shares?
Over the past week, the price has changed by -2.00%, over one month by -6.63%, over three months by -11.67% and over the past year by -0.86%.
Is AD a buy, sell or hold?
What are the forecasts/targets for the AD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.6 | 16.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.9 | 1.7% |
AD Fundamental Data Overview January 26, 2026
P/E Trailing = 14.5066
P/E Forward = 12.6582
P/S = 0.3185
P/B = 2.1171
P/EG = 1.9017
Revenue TTM = 92.14b EUR
EBIT TTM = 3.44b EUR
EBITDA TTM = 7.12b EUR
Long Term Debt = 4.59b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.33b EUR (from shortTermDebt, last fiscal year)
Debt = 4.59b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 805.0m EUR (from netDebt column, last quarter)
Enterprise Value = 29.76b EUR (29.35b + Debt 4.59b - CCE 4.18b)
Interest Coverage Ratio = 4.30 (Ebit TTM 3.44b / Interest Expense TTM 799.0m)
EV/FCF = 6.25x (Enterprise Value 29.76b / FCF TTM 4.76b)
FCF Yield = 15.99% (FCF TTM 4.76b / Enterprise Value 29.76b)
FCF Margin = 5.17% (FCF TTM 4.76b / Revenue TTM 92.14b)
Net Margin = 2.24% (Net Income TTM 2.07b / Revenue TTM 92.14b)
Gross Margin = 26.45% ((Revenue TTM 92.14b - Cost of Revenue TTM 67.77b) / Revenue TTM)
Gross Margin QoQ = 26.46% (prev 26.45%)
Tobins Q-Ratio = 0.61 (Enterprise Value 29.76b / Total Assets 49.03b)
Interest Expense / Debt = 4.49% (Interest Expense 206.0m / Debt 4.59b)
Taxrate = 21.93% (164.0m / 748.0m)
NOPAT = 2.68b (EBIT 3.44b * (1 - 21.93%))
Current Ratio = 0.70 (Total Current Assets 12.14b / Total Current Liabilities 17.27b)
Debt / Equity = 0.33 (Debt 4.59b / totalStockholderEquity, last quarter 13.86b)
Debt / EBITDA = 0.11 (Net Debt 805.0m / EBITDA 7.12b)
Debt / FCF = 0.17 (Net Debt 805.0m / FCF TTM 4.76b)
Total Stockholder Equity = 14.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.28% (Net Income 2.07b / Total Assets 49.03b)
RoE = 14.04% (Net Income TTM 2.07b / Total Stockholder Equity 14.71b)
RoCE = 17.81% (EBIT 3.44b / Capital Employed (Equity 14.71b + L.T.Debt 4.59b))
RoIC = 13.29% (NOPAT 2.68b / Invested Capital 20.20b)
WACC = 5.38% (E(29.35b)/V(33.94b) * Re(5.67%) + D(4.59b)/V(33.94b) * Rd(4.49%) * (1-Tc(0.22)))
Discount Rate = 5.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.66%
[DCF Debug] Terminal Value 87.29% ; FCFF base≈4.54b ; Y1≈5.03b ; Y5≈6.54b
Fair Price DCF = 215.5 (EV 192.87b - Net Debt 805.0m = Equity 192.07b / Shares 891.2m; r=5.90% [WACC]; 5y FCF grow 12.41% → 2.90% )
EPS Correlation: -34.30 | EPS CAGR: -45.70% | SUE: -4.0 | # QB: 0
Revenue Correlation: 67.26 | Revenue CAGR: 2.98% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.61 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=-0.020 | Revisions Net=-5 | Growth EPS=+3.8% | Growth Revenue=+1.5%